Published: Sat, February 04, 2017
Health | By Bessie Ortiz

ULM pharmacy professor receives $10000 donation for breast cancer research

ULM pharmacy professor receives $10000 donation for breast cancer research

The report shows that cancer rates will rise 3.2 per cent for women until 2035, compared to just 0.5 per cent for men. Although more men are overweight, the "obesity timebomb hits women harder" because most cancers linked to weight tend to be more common in females, such as breast, womb and ovarian cancer, says the Daily Telegraph.

Smoking and obesity are partly to blame for the faster rising rates among women, the charity said.

The statistics show that cases of breast cancer are expected to rise from 54,800 in 2014 to more than 71,000 in 2035.

The American Cancer Society estimates that around 20 percent of all diagnosed cancers in the USA are related to unhealthy lifestyles, and excess body weight contributes to as many as one in every five cancer-related deaths.

Sir Harpal Kumar, chief executive of Cancer Research UK, said: 'These new figures reveal the huge challenge we continue to face, both in the UK and worldwide'.

A new study brings breast cancer research decades ahead with new discovery.

The test searches for evidence of so-called hypermethylation, a type of chemical tag affixed to DNA in one or more of six breast cancer-specific genes.

Experts last night called for women to take note of the findings and change their lifestyles to reduce the risk.

Being overweight or obese is also thought to increase the risk of cancer. Smoking is a major factor for cancer in women. More people die from cancer than Aids, malaria and tuberculosis put together.

Research is conducted to find out ways to reduce the concern about cancer and ensure more people survive, particularly for hard-to-treat cancers where the patients have lost faith in life.

One reason is that many more women smoke and drink than before, increasing the risk of lung, liver and mouth cancer.

Breast, prostate, lung and bowel cancer are the most common cancers, accounting for more than half (53 per cent) of new cases of cancer each year in the UK.

According to the Centers for Disease Control and Prevention, 230,815 women were diagnosed with breast cancer and 40,860 died from it in 2013.

"Palbociclib could benefit a large proportion of metastatic breast cancer patients and may even be the closest thing these women would have to a cure in their lifetime".

Baroness Delyth Morgan, chief executive at Breast Cancer Now, said: "This is the clearest illustration to date that the drug appraisal system is totally unfit for objective in assessing first-in-class breast cancer medicines".

Dear Reader: For those who missed my previous column, let me repeat: The relationship between alcohol consumption and breast cancer has been studied multiple times, and there does appear to be a link. Although endocrine therapies can be highly effective in preventing or treating breast cancer, about half of patients who use them exhibit resistance and/or have cancer recurrence.

Like this: